Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Amortization of Deferred Charges of $452000.0 in Q4 2025, up 1.12% quarter-over-quarter from $447000.0 in Q3 2025, and up 4.15% on a YoY basis from $434000.0 in Q4 2024.
Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Amortization of Deferred Charges history runs 16 years deep, the most recent figure standing at $452000.0 for Q4 2025.
- In Q4 2025, Amortization of Deferred Charges rose 4.15% year-over-year to $452000.0; the TTM figure through Dec 2025 stood at $1.8 million (down 37.14% YoY), while the FY2025 annual figure was $1.8 million, down 66.53% from the prior year.
- Amortization of Deferred Charges was $452000.0 for Q4 2025 at Prestige Consumer Healthcare, up from $447000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $1.8 million in Q1 2023 to a low of $428000.0 in Q3 2024.
- Historically, Amortization of Deferred Charges has averaged $916950.0 across 5 years, with a median of $821500.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Amortization of Deferred Charges surged 111.37% in 2021, then slumped 71.07% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $1.4 million in 2021, then plunged by 40.77% to $815000.0 in 2022, then surged by 74.72% to $1.4 million in 2023, then sank by 69.52% to $434000.0 in 2024, then climbed by 4.15% to $452000.0 in 2025.
- The last three Amortization of Deferred Charges figures came in at $452000.0 (Q4 2025), $447000.0 (Q3 2025), and $442000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | 447,000.00 |
| Sep 30, 2025 | 447,000.00 |
| Jun 30, 2025 | 442,000.00 |
| Jun 30, 2025 | 442,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.32 Mn |